Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis
Abstract
Objectives: Immunoparesis (IP) is a risk factor associated with an unfavourable outcome in several plasma cell disorders. It has been suggested that its presence in light-chain (AL) amyloidosis could be associated with worse prognosis. However, the relevance of IP after treatment has not been evaluated to date. The aim of this study was to determine the prognostic impact of IP at diagnosis and one year after treatment onset in patients with AL...
Paper Details
Title
Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis
Published Date
Oct 2, 2017
Journal
Volume
24
Issue
4
Pages
238 - 245
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History